Aspergillus-specific IgM/IgG antibody serostatus of patients hospitalized with moderate-critical COVID-19 in Uganda
dc.contributor.author | Bongomin, Felix | |
dc.contributor.author | Kwizera, Richard | |
dc.contributor.author | Mande, Emmanuel | |
dc.contributor.author | Aloyo, Sharley Melissa | |
dc.contributor.author | Achan, Beatrice | |
dc.contributor.author | Namusobya, Martha | |
dc.contributor.author | Sereke, Senai Goitom | |
dc.contributor.author | Batte, Charles | |
dc.contributor.author | Kiguli, Sarah | |
dc.contributor.author | Baruch Baluku, Joseph | |
dc.contributor.author | Joloba, Moses L | |
dc.contributor.author | Kirenga, Bruce J | |
dc.date.accessioned | 2023-11-30T09:55:54Z | |
dc.date.available | 2023-11-30T09:55:54Z | |
dc.date.issued | 2022-09-03 | |
dc.description.abstract | Invasive pulmonary aspergillosis is known to complicate the coronavirus diseases-2019 (COVID-19), especially those with crit ical illness. We investigated the baseline anti-Aspergillus antibody serostatus of patients with moderate-critical COVID-19 hos pitalized at 3 COVID-19 Treatment Units in Uganda. All 46 tested patients, mean age 30, and 11% with underlying respiratory disease had a negative serum anti-Aspergillus IgM/IgG antibody immunochromatographic test on day 3 (mean) of symptom onset (range 1-26), but follow up specimens to assess seroconversion were not available. | en_US |
dc.identifier.citation | Bongomin, F., Kwizera, R., Mande, E., Aloyo, S. M., Achan, B., Namusobya, M., ... & Kirenga, B. J. (2022). Aspergillus-specific IgM/IgG antibody serostatus of patients hospitalized with moderate-critical COVID-19 in Uganda. African Health Sciences, 22(3), 506-511. | en_US |
dc.identifier.other | https://dx.doi.org/10.4314/ahs | |
dc.identifier.uri | https://hdl.handle.net/20.500.14270/401 | |
dc.language.iso | en | en_US |
dc.publisher | African Health Sciences | en_US |
dc.relation.ispartofseries | ;3 | |
dc.subject | Invasive pulmonary aspergillosis, | en_US |
dc.subject | COVID-19, | en_US |
dc.subject | critical illness, | en_US |
dc.subject | Uganda | en_US |
dc.title | Aspergillus-specific IgM/IgG antibody serostatus of patients hospitalized with moderate-critical COVID-19 in Uganda | en_US |
dc.type | Article | en_US |